Katsuyuki Takeda, MD, PhD Ask a Question Refer Patient Katsuyuki Takeda, MD, is a researcher at National Jewish Health. Dr. Takeda is in the Division of Cell Biology and Department of Pediatrics. Associate Professor Department of Pediatrics Division of Cell Biology 5280 Top Doctors 2022 Previously a 5280 Top Doctor America’s Top Doctors 2015 — Castle Connolly, Medical, Ltd. Recognized in America’s Top Doctors — Castle Connolly, Inc. Best Doctors in America® 2019-2020 — Best Doctors, Inc. Recognized in Best Doctors in America® — Best Doctors, Inc. America’s Top Doctors 2020 — Castle Connolly Medical, Ltd. Email Profile Print Profile Overview Contact Info & Locations Programs & Services Cell Biology Research Areas Alpha-1 Antitrypsin Deficiency Overview Cellular and Molecular Biology Emphysema Asthma Special Interests Research Interests Bronchial asthma; as asthma is the most common chronic inflammatory lung disease, I intend to elucidate the disease mechanisms and explore a new therapeutic approach. Emphysema; as emphysema is a terminal stage of lung damage in lung diseases such as cigarette smoking-associated COPD or Alpha 1-antitrypsin deficiency, which is a genetic disease. My goal is to explore a novel therapeutic tool to repair and normalize damaged lung tissue. Education Education 1993 Okayama Medical School, PhD 1984 Tottori University, MD Awards & Recognition 1998: Astra Research Grant (Competitive Grant for Asthma Research, Japan) 2010: ATS Grant “Alpha-1 Foundation Research Grant in Alpha-1” Board Certification Japanese Society of Internal Medicine Professional Memberships American Thoracic Society (ATS) Japanese Society of Internal Medicine Publications Takeda K, et al. Immunomodulatory Effects of Ambroxol on Airway Hyperresponsiveness and Inflammation. Immune Netw. 2016;16:165-75. Takeda K, et al. Eosinophils contribute to the resolution of lung-allergic responses following repeated allergen challenge. J Allergy Clin Immunol. 2015;135:451-460. Takeda K, et al. The Critical Role of Complement Alternative Pathway Regulator Factor H in Allergen-Induced Airway Hyperresponsiveness and Inflammation. J Immunol. 2012 188:661-7. 9. Takeda K, et al. Effects of combination therapy with montelukast and carbocysteine in allergen-induced airway hyperresponsiveness and airway inflammation. Br J Pharmacol, 2010, 160:1399-407. 14. Takeda K, et al. Vaccine-Induced CD8 T Cell-Dependent Suppression of Airway Hyperresponsiveness and Inflammation. J Immunol. 2009, 183:181-90. Website Information Takeda Lab Ask a Question through Patient Portal Sign in to your My National Jewish Health patient portal account to communicate with your care team, manage appointments, and more. Create an Account Contact Information Office: 877.225.5654Fax: 303.270.2182 Patient Ratings The Patient Rating score is an average of all responses to care provider related questions on our independent rating system, the Press Ganey Patient Satisfaction Survey. This survey is about the patient care experience and does not address crucial characteristics like medical decision-making, prescribing the best therapy, and patient outcomes. Responses are measured on a scale of 1 to 5, with 5 being the best score. Learn more about our patient satisfaction survey. Comments Comments are collected in our Press Ganey Patient Satisfaction Surveys. Patients are de-identified to protect confidentiality and patient privacy. Learn more about our patient satisfaction survey.